WO2007020222A3 - Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof - Google Patents

Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof Download PDF

Info

Publication number
WO2007020222A3
WO2007020222A3 PCT/EP2006/065199 EP2006065199W WO2007020222A3 WO 2007020222 A3 WO2007020222 A3 WO 2007020222A3 EP 2006065199 W EP2006065199 W EP 2006065199W WO 2007020222 A3 WO2007020222 A3 WO 2007020222A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
composition containing
protein fraction
active substance
preparation process
Prior art date
Application number
PCT/EP2006/065199
Other languages
French (fr)
Other versions
WO2007020222A2 (en
Inventor
Piermario Biava
Mariano Bizzarri
Alberto Astaldi
Original Assignee
Steel S R L
Piermario Biava
Mariano Bizzarri
Alberto Astaldi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steel S R L, Piermario Biava, Mariano Bizzarri, Alberto Astaldi filed Critical Steel S R L
Publication of WO2007020222A2 publication Critical patent/WO2007020222A2/en
Publication of WO2007020222A3 publication Critical patent/WO2007020222A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pharmaceutical composition containing a protein fraction, obtained from oviparous embryos at precise stages of differentiation, which is much more active than the crude extract in blocking tumor growth and pathologies controlled by the p53 anti-oncogene. Said fraction, in addition to its greater antitumor advantage, also presents the advantage of better characterization and greater ease of administration in human therapy.
PCT/EP2006/065199 2005-08-12 2006-08-10 Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof WO2007020222A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2005A001572 2005-08-12
IT001572A ITMI20051572A1 (en) 2005-08-12 2005-08-12 PHARMACEUTICAL COMPOSITION CONTAINING AS AN ACTIVE SUBSTANCE A PROTEIN FRACTION EXTRACTED FROM EMBRYOS OF OVIPARIANS IN THE PERIOD OF CELLULAR DIFFERENTIATION AND RELATIVE PREPARATION PROCESS

Publications (2)

Publication Number Publication Date
WO2007020222A2 WO2007020222A2 (en) 2007-02-22
WO2007020222A3 true WO2007020222A3 (en) 2007-04-12

Family

ID=37492494

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2006/065199 WO2007020222A2 (en) 2005-08-12 2006-08-10 Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof

Country Status (2)

Country Link
IT (1) ITMI20051572A1 (en)
WO (1) WO2007020222A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2337537B8 (en) * 2008-03-19 2011-08-01 Joan Cunill Aixela PREPARED FOOD AND PHARMACEUTICAL COMPOSITION CONTAINING AN EMBRYO EXTRACT AND ITS RESPECTIVE USES.
IT1400147B1 (en) * 2010-03-16 2013-05-17 Univ Roma USE OF A MORPHOGENIC FIELD FOR THE REVERSION OF THE PHENOTYPE OF TUMOR CELLS
US9750773B2 (en) * 2014-08-07 2017-09-05 Michele BIAVA Factors extracted from fish embryos and use of mixtures thereof in the control of stem cell multiplication and differentiation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888172A (en) * 1982-09-23 1989-12-19 Alfaceu Corporation Pharmaceutical for treating tumors and methods for making it
WO1998011905A1 (en) * 1996-09-20 1998-03-26 Adriana Carluccio Pharmaceutical composition containing an embryonic or gravid uterus extract as an active substance and relative preparation process
US6037446A (en) * 1990-11-28 2000-03-14 Envision Gestational agents for controlling cell proliferation
EP1374703A1 (en) * 2002-06-20 2004-01-02 Pier Mario Biava Use of a non-human animal embryo extract for the preparation of a nutritive substance and a dietetic-nutraceutical supplement
WO2004043401A2 (en) * 2002-11-13 2004-05-27 Wackvom Limited Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888172A (en) * 1982-09-23 1989-12-19 Alfaceu Corporation Pharmaceutical for treating tumors and methods for making it
US6037446A (en) * 1990-11-28 2000-03-14 Envision Gestational agents for controlling cell proliferation
WO1998011905A1 (en) * 1996-09-20 1998-03-26 Adriana Carluccio Pharmaceutical composition containing an embryonic or gravid uterus extract as an active substance and relative preparation process
EP1374703A1 (en) * 2002-06-20 2004-01-02 Pier Mario Biava Use of a non-human animal embryo extract for the preparation of a nutritive substance and a dietetic-nutraceutical supplement
WO2004043401A2 (en) * 2002-11-13 2004-05-27 Wackvom Limited Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use

Also Published As

Publication number Publication date
WO2007020222A2 (en) 2007-02-22
ITMI20051572A1 (en) 2007-02-13

Similar Documents

Publication Publication Date Title
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
KR102105532B1 (en) Method for derivation of inducible Pluripotent stem cells and inducible Pluripotent stem cells produced using the same
WO2006044860A3 (en) Thiadiazole compounds and methods of use
WO2006032958A3 (en) Composition in micro-pellets with controlled release physiologically active substance, procedure for their preparation and use in the zootechenical sector
KR101487935B1 (en) A pharmaceutical composition comprising extract or fraction of Salvia plebeia R. Br. for preventing or treating STAT3-mediated disease
BR112014011981A2 (en) pharmaceutical formulations
KR101888779B1 (en) Use of isoquinoline alkaloid derivative for preparing drug capable of promoting ampk activity
WO2006010084A3 (en) A system for delivering therapeutic agents into living cells and cell nuclei
WO2009079220A3 (en) Recombinant elastase proteins and methods of manufacturing and use thereof
KR20160064966A (en) Medical composition and applications thereof used for secondary chemotherapy drugs
JP6389958B2 (en) Medicinal use of anti-tumor for rutile pentacyclic triterpene saponins
WO2007020222A3 (en) Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof
WO2007089902A3 (en) Compositions and methods for promoting the healing of tissue of multicellular organisms
CN103045531A (en) Application of ginsenoside Rd for inducing mesenchymal stem cell to be directionally differentiated in to hepatic cell in vitro
CN104274502B (en) A kind of extracting method of the efficient antiinflammatory action compound of euscaphis konishii, product
CN104557909B (en) 3- acyloxy replaces dextrorotation deoxidation tylophorinine derivative, its preparation method and pharmaceutical composition and purposes
WO2009151714A3 (en) Therapeutic for treatment of circulatory shock, ischemia, inflammatory disease and related conditions
US10960035B2 (en) Erodium crassifolium L'Her plant extracts and uses thereof
JP2013209348A (en) Apj activation agent
KR20130085106A (en) Anti-bacterial or anti-inflammatory composition comprising extracts from flower of rosa hybrida as active ingredient
Govindarajan et al. Phytochemical and therapeutic evaluation of leaf and in vitro derived callus and shoot of Solanum trilobatum
ES2909387T3 (en) Plant extracts enriched with ipolamiide derivatives as immunosuppressants to treat immune disorders
MD3972C2 (en) Remedy and method for treating precancerous conditions
KR101746158B1 (en) Composition for ameliorating atopic dermatitis comprising Gypsophila oldhamiana extract and use thereof
KR101757775B1 (en) Composition for prevention or treatment of hair loss comprising extracts of oriental melon leaves

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC EPO FORM 1205A DATED 19-06-2008

122 Ep: pct application non-entry in european phase

Ref document number: 06792772

Country of ref document: EP

Kind code of ref document: A2